Filing Details

Accession Number:
0001543407-18-000031
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-01 08:40:04
Reporting Period:
2018-02-27
Accepted Time:
2018-03-01 08:40:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
10795 Becton Dickinson & Co BDX Surgical & Medical Instruments & Apparatus (3841) 220760120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1628991 E John Gallagher C/O Becton, Dickinson And Company
1 Becton Drive
Franklin Lakes NJ 07417
Vp, Corp Finance And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-27 5,746 $76.18 9,391 No 4 M Direct
Common Stock Disposition 2018-02-27 1,937 $226.08 7,454 No 4 D Direct
Common Stock Disposition 2018-02-27 3,800 $226.08 3,654 No 4 S Direct
Common Stock Disposition 2018-02-27 1,546 $226.08 2,108 No 4 S Direct
Common Stock Disposition 2018-02-28 9 $226.30 2,099 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2018-02-27 5,746 $0.00 5,746 $76.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-11-20 2022-11-20 No 4 M Direct
Footnotes
  1. The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.26. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
  2. The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.30. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
  3. The stock appreciation rights vest in four annual installments beginning November 20, 2013.